Ventripoint Medical System Plus (VMS+)

The Ventripoint Medical System Plus (VMS+) is an advanced software-based adjunct to ultrasound systems, designed for computerized 3D image processing to quantify volumes and ejection fractions of all four cardiac chambers. It utilizes a Knowledge-Based Reconstruction methodology with specific heart chamber catalogs and magnetic tracking for analysis of freehand ultrasound data.

The Ventripoint Medical System Plus (VMS+) is an adjunctive diagnostic tool designed to integrate with existing ultrasound imaging systems, enhancing their capabilities for cardiac assessment. Its core purpose is to record, analyze, store, and retrieve digital ultrasound images, which are then utilized for computerized 3-dimensional image processing. The system is specifically indicated for use in clinical scenarios where obtaining measurements of Left Ventricle (LV), Right Ventricle (RV), Left Atrium (LA), and Right Atrium (RA) volumes and their respective ejection fractions is warranted or desired to inform patient diagnosis and management, allowing for a comprehensive quantitative analysis of all four heart chambers. Technologically, the VMS+ represents an evolution of a prior system, expanding its application from solely the right ventricle to include the left ventricle, left atrium, and right atrium. This expansion is achieved through the incorporation of additional Knowledge-Based Reconstruction (KBR) heart catalogs, which contain a variety of anatomical heart models specific to each chamber. The system maintains the same fundamental scientific approach, employing its KBR database to reconstruct 3D models from freehand 2D ultrasound scans. Key components include proprietary analysis software, a Windows-based operating system, a real-time video capture card, an external ECG trigger for synchronizing image acquisition, and a pulsed DC 6DOF magnetic tracking system to track the ultrasound probe's position. The device's performance, particularly the accuracy of the LV, LA, and RA catalogs, was verified through comprehensive non-clinical bench testing involving automated and manual procedures; clinical studies were not conducted for this iteration. The system also meets relevant medical device safety and electromagnetic compatibility standards.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the accuracy of the VMS+ in determining LV, LA, and RA volumes and ejection fractions compare to gold-standard methods like cardiac MRI, particularly in diverse patient populations with varying cardiac pathologies?; What is the documented inter-operator and intra-operator variability when using the VMS+ for assessing all four cardiac chambers, given the freehand scanning technique and reliance on KBR catalogs?; How does the Knowledge-Based Reconstruction (KBR) algorithm address or flag cases with significant anatomical variations or pathologies that deviate substantially from the heart models in its existing catalogs?; What were the specific quantitative results (e.g., correlation coefficients, Bland-Altman analysis) from the performance bench testing of the LV, LA, and RA catalogs against reference standards or phantoms?; Can the 3D reconstruction data generated by VMS+ be exported or utilized for advanced analyses beyond volumetric measurements, such as strain analysis or computational fluid dynamics modeling?